Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications
TCF7L2 6934 REPAGLINIDE CHEMBL1272 PharmGKB

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID
TCF7L2 rs12255372 TT sulfonamides, urea derivatives efficacy yes Genotype TT is associated with decreased response to sulfonamides, urea derivatives in people with Diabetes Mellitus, Type 2 as compared to genotype GG. 17519421 699639389
TCF7L2 rs290487 TT repaglinide efficacy yes Genotype TT is associated with increased response to repaglinide in people with Diabetes Mellitus, Type 2 as compared to genotypes CC + CT. 20054294 655385762
TCF7L2 rs7903146 TT sulfonamides, urea derivatives efficacy yes Genotype TT is associated with decreased response to sulfonamides, urea derivatives in people with Diabetes Mellitus, Type 2 as compared to genotype CC. 17519421 827826067
TCF7L2 rs7903146 T metformin efficacy yes as measured by decreases in fasting glucose compared to pre-treatment in people with risk factors for type 2 diabetes. Allele T is associated with increased response to metformin as compared to allele C. 29326107 1451105843
TCF7L2 rs7903146 T glipizide efficacy yes as measured by shorter time and a steeper slope to trough glucose levels in people with risk factors for type 2 diabetes. Allele T is associated with increased response to glipizide as compared to allele C. 29326107 1451105880